540 HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis

Gelijkaardige items

• 1574 Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis
  door: Lalezari, Jacob, et al.
  Gepubliceerd in: (2014)
• HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis
  door: Brinson, Cynthia, et al.
  Gepubliceerd in: (2014)
• Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis
  door: Lalezari, Jacob, et al.
  Gepubliceerd in: (2014)
• In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068
  door: Nowicka-Sans, Beata, et al.
  Gepubliceerd in: (2012)
• Model-Based Phase 3 Dose Selection for HIV-1 Attachment Inhibitor Prodrug BMS-663068 in HIV-1-Infected Patients: Population Pharmacokinetics/Pharmacodynamics of the Active Moiety, BMS-626529
  door: Landry, Ishani, et al.
  Gepubliceerd in: (2016)